https://www.indianpharmapost.com/us-fda-inspection-at-gland-pharmas-dundigal-facility-hyderabad-129032022-08-26T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-and-irom-signs-licensing-agreement-for-denosumab-biosimilar-for-japan-129042022-08-26T00:00:00+05:30always0.9https://www.indianpharmapost.com/10th-merck-bioforum-india-2022-on-sept-6-8-129052022-08-26T00:00:00+05:30always0.9https://www.indianpharmapost.com/jb-pharma-ranks-23-in-indian-pharma-market-129062022-08-26T00:00:00+05:30always0.9https://www.indianpharmapost.com/entod-organising-nationwide-campaign-to-encourage-people-to-donate-eyes-129072022-08-26T00:00:00+05:30always0.9https://www.indianpharmapost.com/pristyn-care-witnesses-industry-highest-adoption-of-emr-129082022-08-26T00:00:00+05:30always0.9https://www.indianpharmapost.com/olaparib-approved-in-japan-as-adjuvant-treatment-for-patients-with-high-recurrent-risk-breast-cancer-129092022-08-26T00:00:00+05:30always0.9